Endogenous innate immunity-IFN pathway is important for the efficiency of PEG-IFN/RBV therapy for chronic HCV infection

Yada M｜ Nakamuta M｜ Fujino T｜ Yada R｜ Yoshimoto T｜ Takemoto R｜ Fukuizumi K｜ Harada N｜ Higuchi N｜ Kato M｜ Kotoh K｜ Enjoji M

59th Annual Meeting of the American Association for the Study of Liver Diseases